Dr. Amy Kao joined TVM Capital in April 2023.

Prior to TVM, Amy focused on building and funding healthtech opportunities at Oxford Science Enterprises, the largest university-affiliated investment company in the world. Amy was previously a management consultant at EY Global, advising transaction strategies for health care & life science corporations. She has hands-on experience in venture ideation from Merck KGaA’s Innovation Centre and company creation from her role as Chief of Staff at a Parkinson’s and Dementia digital health start-up.

Her academic work in the gut-brain axis has been published in Nature’s Translational Psychiatry and other high-impact journals. Amy holds a DPhil in Neuroscience from the University of Oxford.

• 

  Associate,Munich in TVM Capital

  Making investments to transform healthcare